FDA Drug recall D-0143-2020
Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Enti…
- FDA Drug
- Class II
- terminated
- Published 2019-10-23
On 2019-10-23 the FDA classified a Class II recall of Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Enti… by Aurobindo Pharma Usa, citing superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0143-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-09-19 |
| Published | 2019-10-23 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Aurobindo Pharma Usa |
| Distribution | US |
Product
Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Entity Amphetamine Product), 20mg, 100-count bottle, RX Only, Distributed by: Aurobindo Pharma USA Inc., Dayton, NJ 08810, NDC 13107-073-01
Reason
Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.
Identifiers
| ndc | 13107-068-50 |
|---|---|
| ndc | 13107-068-01 |
| ndc | 13107-068-25 |
| ndc | 13107-068-05 |
| ndc | 13107-068-99 |
| ndc | 13107-069-50 |
| ndc | 13107-069-01 |
| ndc | 13107-069-25 |
| ndc | 13107-069-05 |
| ndc | 13107-069-99 |
| ndc | 13107-070-50 |
| ndc | 13107-070-01 |
| ndc | 13107-070-25 |
| ndc | 13107-070-05 |
| ndc | 13107-070-99 |
| ndc | 13107-071-50 |
| ndc | 13107-071-01 |
| ndc | 13107-071-25 |
| ndc | 13107-071-05 |
| ndc | 13107-071-99 |
| ndc | 13107-072-50 |
| ndc | 13107-072-01 |
| ndc | 13107-072-25 |
| ndc | 13107-072-05 |
| ndc | 13107-072-99 |
| ndc | 13107-073-50 |
| ndc | 13107-073-01 |
| ndc | 13107-073-25 |
| ndc | 13107-073-05 |
| ndc | 13107-073-99 |
| ndc | 13107-074-50 |
| ndc | 13107-074-01 |
| ndc | 13107-074-25 |
| ndc | 13107-074-05 |
| ndc | 13107-074-99 |
| code_info | Batch 07319032A1, Exp 02/2021 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Other recalls by Aurobindo Pharma Usa
- Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown…
FDA Drug · Class II · 2026-08-12 · Aurobindo Pharma Usa - Acetaminophen Tablets, 325 mg, 100-count bottles, Distributed by: Amazon.com Services LLC, 410 Terry Avenue N., Seattle, WA 98109, NDC 7228…
FDA Drug · Class II · 2025-06-25 · Aurobindo Pharma Usa - Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Wind…
FDA Drug · Class II · 2024-12-25 · Aurobindo Pharma Usa - Cinacalcet Tablets, 90 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-833-30), b) 500-count HDPE bottle (NDC 65862-833-05), Rx Only, D…
FDA Drug · Class II · 2024-12-11 · Aurobindo Pharma Usa - Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only, Di…
FDA Drug · Class II · 2024-12-11 · Aurobindo Pharma Usa
All Aurobindo Pharma Usa recalls
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0143-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.